UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000028488
Receipt number R000032596
Scientific Title The single-arm phase II study evaluating pomalidomide-plus-dexamethasone for relapsed/refractory multiple myeloma and phase II study evaluating pomalidomide-bortezomib-dexamethasone for the patients who are not able to achieve PR after pomalidomide-plus-dexamethasone therapy
Date of disclosure of the study information 2017/08/02
Last modified on 2022/10/09 17:16:21

No. Disposal Last modified on Item of update
1 Insert 2017/08/02 08:41:36
2 Update 2017/08/02 13:46:31 Institutions
Date of disclosure of the study information
3 Update 2017/08/02 13:48:05 Date of disclosure of the study information
4 Update 2018/01/15 15:11:46 Recruitment status
5 Update 2020/08/08 11:47:20 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
6 Update 2020/08/08 11:56:16 Date of IRB
Last follow-up date
7 Update 2022/10/09 17:16:21 Recruitment status